ResearchMoz

Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2013-04-23
No. Of Pages » 115
 
 
   
 The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period. 
   
 This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
3.3.1 Regulatory Support
3.3.2 Increasing Food Demand 
3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
3.4.1 Ethical Issues Associated with Clinical Trials
3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
3.5.1 Emergence of Biosimilars
3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat from Substitutes
3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
4.2.1 Biopharmacy
4.2.1.1 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
4.2.2 Bioservices
4.2.2.1 Global Bioservices Market, 2011 – 2017 (USD Billion)
4.2.3 Bioagriculture
4.2.3.1 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
4.2.4 Bioindustrial
4.2.4.1 Global Bioindustrial Market, 2011 – 2017 (USD Billion)

Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
5.2.1 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 – 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
5.4.1 Global PCR Technology Market, 2010 – 2017 (USD Billion)
5.5 Nanobiotechnology
5.5.1 Global Nanobiotechnology Market, 2010 – 2017 (USDBillion)
5.6 Chromatography
5.6.1 Global Chromatography Market, 2010 – 2017 (USD Billion)
5.7 Dna Sequencing Technology
5.7.1 Global DNA Sequencing Technology Market, 2010 – 2017 (USD Billion)
5.8 Cell Based Assay
5.8.1 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
5.9.1 Global Other Technologies Market, 2010 – 2017 (USD Billion)

Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
6.2.1 North America Market for Biotechnology, 2010 – 2017, (USD Billion)
6.2.2 North America Market Demand For Biotechnology, By Application, 2010 – 2017, (USD Billion)
6.2.2.1 Demand for Biopharmacy in North America, 2010 – 2017, (USD Billion)
6.2.2.2 Demand for Bioservices in North America, 2010 – 2017, (USD Billion)
6.2.2.3 Demand for Bioagriculture in North America, 2010 – 2017, (USD Billion)
6.2.2.4 Demand for Bioindustrial Products in North America, 2010 – 2017, (USD Billion)
6.3 Europe
6.3.1 Europe Market for Biotechnology, 2010 – 2017, (USD Billion)
6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.3.2.1 Demandfor Biopharmacyin Europe, 2010 – 2017, (USD Billion)
6.3.2.2 Demand for Bioservices in Europe, 2010 – 2017, (USD Billion)
6.3.2.3 Demand for Bioagriculture in Europe, 2010 – 2017, (USD Billion)
6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 – 2017, (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Market for Biotechnology, 2010 – 2017, (USD Billion)
6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 – 2017, (USD Billion)
6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 – 2017, (USD Billion)
6.5 Rest Of World
6.5.1 Rest of World Market for Biotechnology, 2010 – 2017, (USD Billion)
6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 – 2017, (USD Billion)
6.5.2.1 Demandfor Biopharmacy in Row, 2010 – 2017, (USDBillion)
6.5.2.2 Demand for Bioservices in Row, 2010 – 2017, (USD Billion)
6.5.2.3 Demand for Bioagriculture in Row, 2010 – 2017, (USD Billion)
6.5.2.4 Demand for Bioindustrial Products in Row, 2010 – 2017, (USD Billion)

Chapter 7 Company Profile
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Swot Analysis
7.1.5 Recent Developments
7.2 Amgen Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.2.4 Swot Analysis
7.2.5 Recent Developments
7.3 Glaxosmithkline
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.3.4 Swot Analysis
7.3.5 Recent Developments
7.4 Johnson And Johnson
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategy.
7.4.4 Swot Analysis
7.4.5 Recent Developments
7.5 Merck
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
7.5.4 Swot Analysis
7.5.5 Recent Developments
7.6 Novartis
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategy
7.6.4 Swot Analysis
7.6.5 Recent Developments
7.7 Novo Nordisk
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies.
7.8.4 Swot Analysis
7.8.5 Recent Developments
7.9 Roche
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Swot Analysis
7.9.5 Recent Developments
7.10 Sanofi - Aventis
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Swot Analysis
7.10.5 Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategy
7.11.4 Swot Analysis
7.11.5 Recent Developments
7.12 Biogen Idec Inc
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategy
7.12.4 Swot Analysis
7.12.5 Recent Developments
7.13 Astra Zeneca
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategy
7.13.4 Swot Analysis
7.13.5 Recent Developments
7.14 Genentech
7.14.1 Company Overview
7.14.2 Financial Overview
7.14.3 Business Strategies
7.14.4 Swot Analysis
7.14.5 Recent Developments
7.15 Genzyme
7.15.1 Company Overview
7.15.2 Financial Overview
7.15.3 Swot Analysis
7.15.4 Recent Developments
7.16 Gilead Sciences
7.16.1 Company Overview
7.16.2 Financial Overview
7.16.3 Swot Analysis
7.16.4 Business Strategies
7.16.5 Recent Developments
7.17 Celgene
7.17.1 Company Overview
7.17.2 Financial Overview
7.17.3 Business Strategy
7.17.4 Swot Analysis
7.17.5 Recent Developments

List of Tables


Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

List of Figures


Fig. 1 Global Biotechnology Market, 2010 – 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 – 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 – 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 – 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 – 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 – 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 – 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 – 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 – 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 – 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 – 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 – 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 – 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 – 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 – 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 – 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 – 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 – 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 – 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 – 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 – 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 – 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 – 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 – 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 – 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 – 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 – 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 – 2017, (USD Billion)

Upcoming Reports:

Greece: market of seats with wooden frames
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the seats with wooden frames market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the seats with wooden frames market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Artificial Implants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Artificial implant is the procedure of replacement of a biological structure through a medical device. This medical device can be heart, dental fixtures or similar body parts enhancing or strengthening the damaged or existing biological structure. Medical implants are artificially manufactured or so called as manmade, contrast to the transplanting organs or tissue. Some of the implants include electronic devices too such as pacemaker while others are bioactive. The advent of the artificial implants has opened new horizons for the medical sector helping the patients with damaged...
Poland: unwrought copper market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the unwrought copper market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the unwrought copper market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Increased Freedom for Siemens Healthcare Through Reworked Board
Jan 27, 2015  
Siemens Chief Executive Officer, Joe Kaeser, has successfully reshuffled the management board of the company. The largest engineering company in Europe, Siemens, is now ready to submit its healthcare operations to greater internal independence. Bernd Montag has been approached to take care of the healthcare unit. On the other hand, chief technology officer and personnel chief Siegfried...
Declining Oil Prices in Vietnam - Problematic for Managing the Budget Deficit
Jan 27, 2015  
Falling prices of oil are fuelling the domestic consumption pattern in Vietnam and is as a result giving a significant boost to the Vietnamese economy. This is also presenting a dilemma for the government since the country’s efforts to control the budget deficit is also getting threatened. As per Bui Duc Thu, a member of the National Assembly’s finance committee, a certain decline...
Oil Prices by far the Lowest in Six Years
Jan 27, 2015  
In almost six years, the amount of oil traded reached the lowest levels since the OPEC’s warning that prices may rise without new investment in production that failed to shift the focus of the market from more immediate signs of a global supply glut. As per the OPEC Secretary-General Abdalla El-Badri changes in futures were quite low in New York after declining 1% on Monday. A hike to...
The Georgia Deal to Fuel the Southern Solar Strategy
Jan 27, 2015  
It is anticipated that the southern part of U.S. will become the center of the solar industry within the next six to twelve months if all goes as per plans in Georgia. In January, a compromise bill was introduced by Mike Dudgeon, the State Representative on the third-party ownership of solar systems in the state. As per this legislation, companies like Sungevity or SolarCIty can install...
Fund for Innovative Technologies Set Up by Hyundai Motor
Jan 27, 2015  
Hyundai Motor Group on Tuesday announced that it will be launching a fund worth US$163.9 million in order to aid business ventures and the development of innovative technologies with regard to automobiles and hydrogen fuel cells. With ownership of two of South Korea’s largest car manufacturers – Kia Motors Corp. and Hyundai Motor Co., Hyundai Motor Group said that of the 177.5...